Search

Your search keyword '"Hide, Michihiro"' showing total 1,112 results
Start Over Author "Hide, Michihiro"
1,112 results on '"Hide, Michihiro"'

53. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative

Author

Zuberbier, Torsten, primary, Abdul Latiff, Amir, additional, Aggelidis, Xenofon, additional, Augustin, Matthias, additional, Balan, Radu‐Gheorghe, additional, Bangert, Christine, additional, Beck, Lisa, additional, Bieber, Thomas, additional, Bernstein, Jonathan A., additional, Bertolin Colilla, Marta, additional, Berardi, Alejandro, additional, Bedbrook, Anna, additional, Bindslev‐Jensen, Carsten, additional, Bousquet, Jean, additional, de Bruin‐Weller, Marjolein, additional, Bruscky, Dayanne, additional, Buyuktiryaki, Betul, additional, Canonica, Giorgio Walter, additional, Castro, Carla, additional, Chanturidze, Natia, additional, Chong‐Neto, Herberto Jose, additional, Chu, Chia‐Yu, additional, Chularojanamontri, Leena, additional, Cork, Michael, additional, Criado, Roberta F. J., additional, Barredo, Laia Curto, additional, Custovic, Adnan, additional, Darsow, Ulf, additional, Emurlai, Arben, additional, de Pablo, Ana, additional, Del Giacco, Stefano, additional, Girolomoni, Giampiero, additional, Deleva Jovanova, Tanja, additional, Deleuran, Mette, additional, Douladiris, Nikolaos, additional, Duarte, Bruno, additional, Dubakiene, Ruta, additional, Eller, Esben, additional, Engel‐Yeger, Batya, additional, Ensina, Luis Felipe, additional, Filho, Nelson Rosario, additional, Flohr, Carsten, additional, Fomina, Daria, additional, Francuzik, Wojciech, additional, Galimberti, Maria Laura, additional, Giménez‐Arnau, Ana M., additional, Godse, Kiran, additional, Mortz, Charlotte Gotthard, additional, Gotua, Maia, additional, Hide, Michihiro, additional, Hoetzenecker, Wolfram, additional, Hunzelmann, Nicolas, additional, Irvine, Alan, additional, Jack, Carolyn, additional, Kanavarou, Ioanna, additional, Katoh, Norito, additional, Kinaciyan, Tamar, additional, Kocatürk, Emek, additional, Kulthanan, Kanokvalai, additional, Lapeere, Hilde, additional, Lau, Susanne, additional, Machado Forti Nastri, Mariana, additional, Makris, Michael, additional, Mansour, Eli, additional, Marsland, Alexander, additional, Morelo Rocha Felix, Mara, additional, Moschione Castro, Ana Paula, additional, Nettis, Eustachio, additional, Nicolas, J. F., additional, Nosbaum, Audrey, additional, Odemyr, Mikaela, additional, Papapostolou, Niki, additional, Parisi, Claudio A. S., additional, Paudel, Sushil, additional, Peter, Jonny, additional, Pokharel, Prakash, additional, Puig, Luis, additional, Quint, Tamara, additional, Ramon, German Dario, additional, Regateiro, Frederico, additional, Ricci, Giampaolo, additional, Rosario, Cristine, additional, Sackesen, Cansin, additional, Schmid‐Grendelmeier, Peter, additional, Serra‐Baldrich, Esther, additional, Siemens, Kristina, additional, Smith, Cathrine, additional, Staubach, Petra, additional, Stevanovic, Katarina, additional, Su‐Kücük, Özlem, additional, Sussman, Gordon, additional, Tavecchio, Simona, additional, Teovska Mitrevska, Natasa, additional, Thaci, Diamant, additional, Toubi, Elias, additional, Traidl‐Hoffmann, Claudia, additional, Treudler, Regina, additional, Vadasz, Zahava, additional, van Hofman, Ingrid, additional, Ventura, Maria Teresa, additional, Wang, Zhao, additional, Werfel, Thomas, additional, Wollenberg, Andreas, additional, Yang, Ariana, additional, Weng Yew, Yik, additional, Zhao, Zuotao, additional, Zwiener, Ricardo, additional, and Worm, Margitta, additional

Published
2023
Full Text
View/download PDF

54. Time Course of Priming Effect of TF Inducers on Synergistic TF Expression and Intra-Cellular Gap Formation of Human Vascular Endothelial Cells via the Extrinsic Coagulation Cascade

Author

Matsubara, Daiki, primary, Kunieda, Takuma, additional, Yanase, Yuhki, additional, Takahagi, Shunsuke, additional, Uchida, Kazue, additional, Kawaguchi, Tomoko, additional, Ishii, Kaori, additional, Tanaka, Akio, additional, Ozawa, Koichiro, additional, and Hide, Michihiro, additional

Published
2023
Full Text
View/download PDF

57. The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update

Author

Maurer, Marcus, Magerl, Markus, Ansotegui, Ignacio, Aygören-Pürsün, Emel, Betschel, Stephen, Bork, Konrad, Bowen, Tom, Boysen, Henrik Balle, Farkas, Henriette, Grumach, Anete S., Hide, Michihiro, Katelaris, Constance, Lockey, Richard, Longhurst, Hilary, Lumry, William R., Martinez-Saguer, Inmaculada, Moldovan, Dumitru, Nast, Alexander, Pawankar, Ruby, Potter, Paul, Riedl, Marc, Ritchie, Bruce, Rosenwasser, Lanny, Sánchez-Borges, Mario, Zhi, Yuxiang, Zuraw, Bruce, and Craig, Timothy

Published
2018
Full Text
View/download PDF

63. ISID1357 - Construction of the atopic dermatitis sweat function registry (ADSF Registry) for sweating disturbance in atopic dermatitis evaluated by automatic assessment for skin microstructure and sweating.

Author

Imamura, Shinya, primary, Mizuno, Mayuko, primary, Oda, Yoshiko, primary, Fukumoto, Takeshi, primary, Hayashida, Yuki, primary, Nakamoto, Kenta, primary, Takahagi, Shunsuke, primary, Mizuno, Hayato, primary, Murota, Hiroyuki, primary, Hide, Michihiro, primary, Aoyama, Yumi, primary, Fukunaga, Atsushi, primary, and Tetsushi, Koide, primary

Published
2023
Full Text
View/download PDF

64. Remibrutinib: A Novel BTKi in Development for MS With a Favorable Safety Profile in Various Autoimmune Disorders (P7-3.015)

Author

Williams, Mitzi, primary, Airas, Laura, additional, Chitnis, Tanuja, additional, Saini, Sarbjit, additional, Hide, Michihiro, additional, Sussman, Gordon, additional, Nakahara, Jin, additional, Bermel, Robert, additional, Dörner, Thomas, additional, Loop, Brett, additional, Ziehn, Marina, additional, Willi, Roman, additional, Kieseier, Bernd C., additional, Nikolaev, Ivan, additional, Haemmerle, Sibylle, additional, Zharkov, Artem, additional, Siegel, Richard, additional, Cenni, Bruno, additional, Wiendl, Heinz, additional, Maurer, Marcus, additional, Giménez-Arnau, Ana, additional, and Montalban, Xavier, additional

Published
2023
Full Text
View/download PDF

66. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

Author

Maurer, Marcus, Ensina, Luis Felipe, Gimenez-Arnau, Ana Maria, Sussman, Gordon, Hide, Michihiro, Saini, Sarbjit, Grattan, Clive, Fomina, Daria, Rigopoulos, Dimitrios, Berard, Frederic, Canonica, Giorgio Walter, Rockmann, Heike, Irani, Carla, Szepietowski, Jacek C, Leflein, Jeffrey, Bernstein, Jonathan A, Peter, Jonny G, Kulthanan, Kanokvalai, Godse, Kiran, Ardusso, Ledit, Ukhanova, Olga, Staubach, Petra, Sinclair, Rodney, Gogate, Shaila, Thomsen, Simon Francis, Tanus, Tonny, Ye, Young Min, Burciu, Alis, Barve, Avantika, Modi, Darshna, Scosyrev, Emil, Hua, Eva, Letzelter, Kerstin, Varanasi, Vineeth, Patekar, Manmath, Severin, Thomas, Rosana, Agondi, Ahmed, Al Waily, Fabio, Almerigogna, Miguel Angel Tejedor, Alonso, Alfred, Ammoury, Eng Kim, Anne Goh, Robert, Anolik, Ledit, Ardusso, Petr, Arenberger, Nandini, AS, Mohammad, Asefi, Natalia, Astafieva, Anil, Badhwar, Esther Serra, Baldrich, Christine, Bangert, Annick, Barbaud, Zsuzsanna, Bata-Csorgo, Andrea, Bauer, Frederic, Berard, Beata, Bergler-Czop, Gary D, Berman, Jonathan, Bernstein, Subhash Chandra, Bharija, Ramesh M, Bhat, Isabelle, Boccon-Gibod, Ivan, Botev, Knut, Brockow, Philipp, Buck, Paula, Busse, Regis, Campos, Giorgio Walter, Canonica, Irani, Carla, Julia Maria Del, Carmen, Jaime Del, Carpio, Mamatha, Chadalavada, Yoon-Seok, Chang, Amarjit, Cheema, Yi Hsing, Chen, Yuko, Chinuki, Soyun, Cho, Jeong-Hee, Choi, Chia-Yu, Chu, Ronit, Confino, Jonathan, Corren, Roberta, Criado, Claudia De La, Cruz, David M, Cypcar, Pramila, Daftary, Inna, Danilycheva, Kenneth, Dawes, Michelle Joy, De Vera, James, Deangelo, Stefano, Del Giacco, Diana, Deleanu, John, Delgado, Richard, DeMera, Mohamed, Denguezli, Heinrich, Dickel, Le Huu, Doanh, Sinan, Dogan, Marie Sylvie, Doutre, Anne Sophie, Dupond, Anton, Edin, Kent, EDWARD, Swarna, Ekanayake-Bohling, Daniel, Elbirt, David, Elkayam, Anne, Ellis, Shaunagh, Emanuel, Alexander, Emeliyanov, Burhan, Engin, Luis Felipe, Ensina, Ignacio Antepara, Ercoreca, Safiye, Ergun, Jose Luis Lopez, Estebaranz, Rustem, Fassakhov, Daria, Fomina, Linda, Ford, Mariangela, Francomano, Todd, Funkhouser, Remi, Gagnon, Ricardo, Galimberti, Cesar Alberto, Galvan Calle, Clovis, Galvao, Gabriel, Gattolin, Pierre-Dominique, Ghislain, Ana Maria, Gimenez Arnau, Elliot, Ginchansky, Francoise, Giordano-Labadie, Stanislav, Givirovsky, Kiran, Godse, Shaila, Gogate, Alan, Goldsobel, Francisca, Gomez, Rene Maximiliano, Gomez, Erika, Gonzalez, Paula Ribo, Gonzalez, Dimitar, Gospodinov, Clive, Grattan, Martine, Grosber, Gary, Gross, Francisco Jose Gomez, Guimera Martin-Neda, Rolland, Gyulai, Svetlana, Hadvabova, Suzana Ljubojevic, Hadzavdic, Hadi, Hamam, Daniela, Hasicova, Koremasa, Hayama, Pravin, Hissaria, Anna, Hjerppe, Ivan, Hlinka, Moises Labrador, Horrillo, Connie, Hsu, Yu-Huei, Huang, Iftikhar, Hussain, Atsuyuki, Igarashi, Beata, IMKO-WALCZUK, Huseyin Serhat, Inaloz, Rossella, Intravaia, Neal, Jain, Sanjeev, Jain, Sanjeev, Jain, Thilo, Jakob, Ruth Cerino, Javier, Antonio, João, Luiza Marek, Jozefowicz, Chang-Gyu, Jung, Martin, Kaatz, Nida, Kacar, Henry, Kanarek, Iva, Karlova, Alexander, Kastanayan, Jana, Kazandjieva, Johannes, Kern, Aharon, Kessel, Neena, Khanna, HeeJoo, Kim, Nancy, Kim, Sang-Ha, Kim, Tae-bum, Kim, Kulli, Kingo, Andreas, Kleinheinz, Janka, Komova, Evangelia, Kompoti, Tomas, Kopal, Peter, Kozub, Dorota, Krasowska, Beata, Krecisz, Burkhard, Kreft, Satsuki, Kubota, Hitoshi, Kudo, Teja, Kulkarni, Kanokvalai, Kulthanan, Akihiro, Kume, Maciej, Kupczyk, Edward, Lain, Bobby, Lanier, Hilde, Lapeere, Griselle Ortiz, Lasanta, Svetlana, Lazareva, Laura, Lazzeri, Dennis, Ledford, Donghun, Lee, Haur Yueh, Lee, Jeffrey, Leflein, Nicolas, Leitz, Nancy, Levin, Hermenio, Lima, Undine, Lippert, Brian, Lipson, Paula, Luna, Gabriel, Magarinos, Satyaprakash, Mahajan, Michail, Makris, Alejandro, Malbran, Ahmed Manjra, Manjra, Michael, Manning, Maria, Manrique, Adriana, Marcipar, Mariano, Marini, Veronique Del, Marmol, Jorge, Maspero, Tomoko, Matsuda, Jonathan, Matz, Marcus, Maurer, Wendy, McFalda, Anne, Mclaughlin, Iris, Medina, Rajesh Dutt, Mehta, Stephan, Meller, Steven, MELTZER, Raisa, Meshkova, Dorin, Mihalache, Francisco Javier, Miquel, Mourad, Mokni, J, Molhoek, Efrain, Montano, Sabine, Mueller, Javier Pedraz, Munoz, Toshikazu, Nagakura, Joanna, Narbutt, Ignasi Figueras, Nart, Ma. Lourdes M, Nebrida-Idea, Trong Hao, Nguyen, Johannes, Niesmann, Violeta Zaragoza, Ninet, Hiromitsu, Noguchi, Yuko Chinuki, Nomura, Roman, Nowicki, Tokuya, Omi, Robert, Onder, Ivan, Orojan, Francisco Javier, Ortiz de Frutos, Kim, Papp, Claudio, Parisi, Chun Wook, Park, Heungwoo, Park, Jungwon, Park, Young Min, Park, Viviana, Parra, Thierry, Passeron, Justine, Pasteur, Shivakumar, Patil, Vergil, Patrascu, Sylvia, Pauser, Anna Wojas, Pelc, Jonathan Grant, Peter, Wolfgang, Pfuetzner, Nicola, Pimpinelli, Andreas, Pinter, Cristian, Pizarro, Karel, Pizinger, Jarmila, Plutinska, Todor, Popov, Veronika, Popova, Marta Ferrer, Puga, Lara Ferrandiz, Pulido, Anca, Purcaru, Ulrike, Raap, Anna, Rajchel, John, Ramey, Ma Deanna Santos, Ramiscal, German Dario, Ramon, Syed, Rehman, Adam, Reich, Norbert, Reider, Krista, Ress, Dimitrios, Rigopoulos, Enrique, Rivas, Heike, Rockmann, Pierre-Paul, Roquet-Gravy, Menachem, Rottem, Vermen Verallo, Rowell, Franziska, Rueff, Juan Alberto Ruano, Ruiz, Juan, Russo, Ronald, Saff, Sarbjit, Saini, Maria, Salazar, Juan Francisco Silvestre, Salvador, Jorge, Sanchez, Florica, Sandru, Mark, Scarupa, Knut, Schaekel, Sibylle, Schliemann, Rik, Schrijvers, Beate, Schwarz, Andreas, Schwinn, Sudhir, Sekhsaria, Nilgun, Senturk, Seong Jun, Seo, Mercedes Rodriguez, Serna, Faradiba, Serpa, Paul A, Shapero, Eriko, Shinkawa, Jan-Christoph, Simon, Rodney, Sinclair, Ralfi, Singer, Dareen D, Siri, Karl, Sitz, Adam, Smialowski, Andrew, Smith, Morten, Soerensen, Wiebke, Sondermann, Haejun, Song, Dmitrii, Sonin, Weily, Soong, Daniel, Soteres, Maria, Staevska-Kotasheva, Petra, Staubach-Renz, Nisha Su Yien, Subash, Gordon, Sussman, Ake Svensson, Svensson, Ekaterini, Syrigou, Andrea, Szegedi, Jacek, Szepietowski, Shunsuke, Takahagi, Yuval, Tal, Neetu, Talreja, Wooi Chiang, Tan, Ricardo, Tan, Jyh Jong, Tang, Tonny, Tanus, Martha, Tarpay, Shang Ian, Tee, Craig, Teller, Florence, Tetart, Aurelie Du, Thanh, Suganthi, Thevarajah, Simon Francis, Thomsen, Carl, Thornblade, Milan, Tjioe, Alberto, Tolcachier, Celeste, Tolentino, Athanasios, Tsianakas, Ilia, Tsingov, Hamida, Turki, Olga, Ukhanova, Jens, Ulrich, Meltem, Uslu, Fernando, Valenzuela, Solange, Valle, Martijn, van Doorn, Jirina, Vankova, Suneel, Vartak, Christine, Vidouria, Sebastian, Volc, Gerald, Volcheck, Nicola, Wagner, Irena, Walecka-Herniczek, Penpun, Wattanakrai, Bettina, Wedi, Steven, Weinstein, Vesarat, Wessagowit, Hugh, Windom, Akiko, Yagami, Aisaku, Yamamoto, Shinichiro, Yasumoto, Young Min, Ye, Jose Cevallos, Yepez, Sang Woong, Youn, Hana, Zelenkova, Oleg, Ziganshin, and Matthew, Zook

Abstract

Many patients with chronic spontaneous urticaria (CSU) do not achieve complete control of their symptoms with current available treatments. In a dose-finding phase 2b study, ligelizumab improved urticaria symptoms in patients with H1-antihistamine (H1-AH) refractory CSU. Here, we report the efficacy and safety outcomes from two ligelizumab phase 3 studies.

Published
2024
Full Text
View/download PDF

67. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan

Author

Watanabe, Shinichi, Ohnishi, Takamitsu, Yuasa, Akira, Kiyota, Hiroshi, Iwata, Satoshi, Kaku, Mitsuo, Watanabe, Akira, Sato, Junko, Hanaki, Hideaki, Manabe, Motomu, Suzuki, Tamio, Otsuka, Fujio, Aihara, Michiko, Iozumi, Ken, Tamaki, Takeshi, Funada, Yuichi, Shinozaki, Mikio, Kobayashi, Motoko, Okuda, Masaru, Kikyo, Go, Kikuchi, Kumi, Okada, Yoshitane, Takeshima, Masanori, Kaneko, Osamu, Ogawa, Natsuki, Ito, Rie, Okuyama, Ryuhei, Shimada, Shinji, Shimizu, Tadamichi, Hatta, Naohito, Manabu, Maeda, Tsutsui, Kiyohiro, Tanaka, Toshihiro, Miyachi, Yoshiki, Asada, Hideo, Furukawa, Fukumi, Kurokawa, Ichiro, Iwatsuki, Keiji, Hide, Michihiro, Muto, Masahiko, Yamamoto, Osamu, Niihara, Hiroyuki, Takagaki, Kenji, Kubota, Yasuo, Sayama, Koji, Sano, Shigetoshi, Furue, Masutaka, and Kanekura, Takuro

Published
2017
Full Text
View/download PDF

74. Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open‐label study.

Author

Hide, Michihiro, Ohsawa, Isao, Nurse, Christina, and Yu, Ming

Abstract

The safety and efficacy of lanadelumab for the prevention of hereditary angioedema (HAE) attacks have not been studied in Japanese patients. We report outcomes from a phase 3, multicenter, open‐label study (NCT04180163) of lanadelumab in Japanese patients with HAE. Japanese patients with HAE aged ≥12 years with ≥1 investigator‐confirmed HAE attack during the 4‐week run‐in baseline period were enrolled into the study and received lanadelumab 300 mg every 2 weeks subcutaneously for 52 weeks. Dosing could be reduced to 300 mg every 4 weeks during the second 26‐week treatment period if patients had well‐controlled symptoms (e.g., attack‐free) for 6 months. The primary efficacy endpoint was no investigator‐confirmed HAE attacks (attack‐free status) during days 0–182. Other outcomes included the rate of investigator‐confirmed HAE attacks per month (28 days) and lanadelumab safety. Twelve patients (mean ± SD age 41.9 ± 12.4 years) were enrolled. During the first 26 weeks (days 0–182), five (41.7%) patients were attack‐free. The mean ± SD HAE attack rate per month decreased by 74.0%, from 3.8 ± 2.4 during baseline to 1.2 ± 2.6 during the overall 52‐week treatment period. There were no deaths or discontinuations due to treatment‐emergent adverse events (TEAEs), no severe or serious TEAEs related to lanadelumab, and no positive anti‐drug antibody results. The most frequent TEAEs were injection‐site reactions (37 events in six patients). Most of the injection‐site reaction adverse events were mild in severity. Results of this study support the findings from two global phase 3 studies for lanadelumab use as prophylactic therapy in Japanese patients with HAE. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

75. Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open‐label study.

Author

Hide, Michihiro, Wang, Yi, Dote, Nobuhito, Miyakawa, Kou, Sugiura, Kenkichi, and Ishida, Kazuyuki

Abstract

We evaluated the safety, efficacy, and pharmacokinetics of subcutaneous weight‐adjusted icatibant for the treatment of acute hereditary angioedema attacks in Japanese pediatric patients. Two patients (aged 10–13 and 6–9 years) received icatibant for a total of four attacks. Each attack was abdominal and/or cutaneous and was treated with a single icatibant injection. Mild or moderate injection‐site reactions were the only adverse events reported. Time to onset of symptom relief was 0.9–1.0 h. Icatibant was rapidly absorbed, with a pharmacokinetic profile consistent with previous studies. Simulated exposure levels were consistent with non‐Japanese pediatric patients. These results support the safety and efficacy of icatibant in Japanese pediatric patients. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

76. English version of Japanese guidance for biologics in treating atopic dermatitis.

Author

Saeki, Hidehisa, Akiyama, Masashi, Abe, Masatoshi, Igarashi, Atsuyuki, Imafuku, Shinichi, Ohya, Yukihiro, Katoh, Norito, Kameda, Hideto, Kabashima, Kenji, Tsunemi, Yuichiro, Hide, Michihiro, and Ohtsuki, Mamitaro

Abstract

This is the English version of the Japanese guidance for biologics in treating atopic dermatitis (AD). The signaling pathway mediated by interleukin (IL)‐4 and IL‐13 contributes to type 2 inflammatory responses and plays an important role in the pathogenesis of AD. IL‐31 is a cytokine mainly produced by activated T cells and is known to be involved in the pruritus of AD. Biologics for AD have been approved, including dupilumab, an anti‐IL‐4 receptor α antibody that was approved for expanded use in AD in 2018. In 2022, nemolizumab, an anti‐IL‐31 receptor α antibody, was approved for pruritus of AD, and tralokinumab, an anti‐IL‐13 antibody, was approved for AD. Physicians who intend to use these drugs should sufficiently understand and comply with the contents of the guidelines prepared by the Japanese Ministry of Health, Labour, and Welfare to promote the optimal use of the drugs. In treatment with biologics, it is important to consider disease factors (activity and severity), treatment factors (dosage and administration as well as the efficacy and safety), and patients' background characteristics (age and comorbidities) and share this information with patients when choosing treatment options. This guidance was developed for board‐certified dermatologists who specialize in treating AD, and for promoting the proper use of biologics, taking into account the variety of factors in individual patients. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

77. Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol

Author

Nakahara, Takeshi, Izuhara, Kenji, Onozuka, Daisuke, Nunomura, Satoshi, Tamagawa-Mineoka, Risa, Masuda, Koji, Ichiyama, Susumu, Saeki, Hidehisa, Kabata, Yudai, Abe, Riichiro, Ohtsuki, Mamitaro, Kamiya, Koji, Okano, Tatsuro, Miyagaki, Tomomitsu, Ishiuji, Yozo, Asahina, Akihiko, Kawasaki, Hiroshi, Tanese, Keiji, Mitsui, Hiroshi, Kawamura, Tatsuyoshi, Takeichi, Takuya, Akiyama, Masashi, Nishida, Emi, Morita, Akimichi, Tonomura, Kyoko, Nakagawa, Yukinobu, Sugawara, Koji, Tateishi, Chiharu, Kataoka, Yoko, Fujimoto, Rai, Kaneko, Sakae, Morita, Eishin, Tanaka, Akio, Hide, Michihiro, Aoki, Natsuko, Sano, Shigetoshi, Matsuda-Hirose, Haruna, Hatano, Yutaka, Takenaka, Motoi, Murota, Hiroyuki, Katoh, Norito, and Furue, Masutaka

Published
2020
Full Text
View/download PDF

83. Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study)

Author

Nakahara, Takeshi, primary, Izuhara, Kenji, additional, Onozuka, Daisuke, additional, Saeki, Hidehisa, additional, Nunomura, Satoshi, additional, Takenaka, Motoi, additional, Matsumoto, Mai, additional, Kataoka, Yoko, additional, Fujimoto, Rai, additional, Kaneko, Sakae, additional, Morita, Eishin, additional, Tanaka, Akio, additional, Hide, Michihiro, additional, Okano, Tatsuro, additional, Miyagaki, Tomomitsu, additional, Aoki, Natsuko, additional, Nakajima, Kimiko, additional, Ichiyama, Susumu, additional, Kido‐Nakahara, Makiko, additional, Tonomura, Kyoko, additional, Nakagawa, Yukinobu, additional, Tamagawa‐Mineoka, Risa, additional, Masuda, Koji, additional, Takeichi, Takuya, additional, Akiyama, Masashi, additional, Ishiuji, Yozo, additional, Katsuta, Michie, additional, Kinoshita, Yuki, additional, Tateishi, Chiharu, additional, Yamamoto, Aya, additional, Morita, Akimichi, additional, Matsuda‐Hirose, Haruna, additional, Hatano, Yutaka, additional, Kawasaki, Hiroshi, additional, Tanese, Keiji, additional, Ohtsuki, Mamitaro, additional, Kamiya, Koji, additional, Kabata, Yudai, additional, Abe, Riichiro, additional, Mitsui, Hiroshi, additional, Kawamura, Tatsuyoshi, additional, Tsuji, Gaku, additional, Katoh, Norito, additional, and Furue, Masutaka, additional

Published
2022
Full Text
View/download PDF

85. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan

Author

Takimoto-Ito, Riko, primary, Kambe, Naotomo, additional, Kogame, Toshiaki, additional, Nomura, Takashi, additional, Izawa, Kazushi, additional, Jo, Tomoyasu, additional, Kazuma, Yasuhiro, additional, Yoshifuji, Hajime, additional, Tabuchi, Yuya, additional, Abe, Hiroyasu, additional, Yamamoto, Mayuko, additional, Nakajima, Kimiko, additional, Tomita, Ozumi, additional, Yagi, Yosuke, additional, Katagiri, Kazumoto, additional, Matsuzaka, Yuki, additional, Takeuchi, Yohei, additional, Hatanaka, Miho, additional, Kanekura, Takuro, additional, Takeuchi, Sora, additional, Kadono, Takafumi, additional, Fujita, Yuya, additional, Migita, Kiyoshi, additional, Fujino, Takahiro, additional, Akagi, Takahiko, additional, Mukai, Tomoyuki, additional, Nagano, Tohru, additional, Kawano, Mitsuhiro, additional, Kimura, Hayato, additional, Okubo, Yukari, additional, Morita, Akimichi, additional, Hide, Michihiro, additional, Satoh, Takahiro, additional, Asahina, Akihiko, additional, Kanazawa, Nobuo, additional, and Kabashima, Kenji, additional

Published
2022
Full Text
View/download PDF

87. Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey

Author

Li, Philip H., primary, Pawankar, Ruby, additional, Thong, Bernard Yu-Hor, additional, Fok, Jie Shen, additional, Chantaphakul, Hiroshi, additional, Hide, Michihiro, additional, Jindal, Ankur Kumar, additional, Kang, Hye-Ryun, additional, Abdul Latiff, Amir Hamzah, additional, Lobo, Rommel Crisenio M., additional, Munkhbayarlakh, Sonomjamts, additional, Nguyen, Dinh Van, additional, Shyur, Shyh-Dar, additional, Zhi, Yuxiang, additional, and Maurer, Marcus, additional

Published
2022
Full Text
View/download PDF

88. The expression of prolyl isomerase Pin1 is expanded in the skin of patients with atopic dermatitis and facilitates IL ‐33 expression in HaCaT cells

Author

Kanamoto, Mayu, primary, Takahagi, Shunsuke, additional, Aoyama, Shunya, additional, Kido, Yuri, additional, Nakanishi, Mikako, additional, Naito, Miki, additional, Kanna, Machi, additional, Yamamotoya, Takeshi, additional, Tanaka, Akio, additional, Hide, Michihiro, additional, Asano, Tomoichiro, additional, and Nakatsu, Yusuke, additional

Published
2022
Full Text
View/download PDF

98. A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan

Author

Saito, Ryo, primary, Takahagi, Shunsuke, additional, Nakano, Fumi, additional, Furutani, Kiyoshi, additional, Mihara, Shoji, additional, Numata, Tsunemi, additional, Kameyoshi, Yoshikazu, additional, Tanaka, Toshihiko, additional, Shindo, Hajime, additional, Niimi, Naomasa, additional, Iwamoto, Kazumasa, additional, Hiragun, Takaaki, additional, Hiragun, Makiko, additional, Tanaka, Akio, additional, and Hide, Michihiro, additional

Published
2022
Full Text
View/download PDF

100. English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021

Author

Saeki, Hidehisa, primary, Ohya, Yukihiro, additional, Furuta, Junichi, additional, Arakawa, Hirokazu, additional, Ichiyama, Susumu, additional, Katsunuma, Toshio, additional, Katoh, Norito, additional, Tanaka, Akio, additional, Tsunemi, Yuichiro, additional, Nakahara, Takeshi, additional, Nagao, Mizuho, additional, Narita, Masami, additional, Hide, Michihiro, additional, Fujisawa, Takao, additional, Futamura, Masaki, additional, Masuda, Koji, additional, Matsubara, Tomoyo, additional, Murota, Hiroyuki, additional, and Yamamoto‐Hanada, Kiwako, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results